Scott Peters, VP

Professional Overview

Scott Peters is an accomplished finance executive with extensive experience in the pharmaceutical industry. As the Vice President at Pliant Therapeutics, he leverages his deep expertise in corporate accounting, financial reporting, and strategic business partnering to drive the company's financial performance and growth initiatives.

Experience Summary

Current Role

As the Vice President at Pliant Therapeutics since February 2021, Scott is responsible for overseeing the company's financial operations, including accounting, treasury, tax, and financial planning and analysis. He works closely with the executive team to align financial strategies with the organization's overall business objectives, ensuring efficient resource allocation and strategic decision-making.

Career Progression

Prior to his current role, Scott held several leadership positions at Portola Pharmaceuticals, where he most recently served as the Executive Director, Corporate Controller. In this capacity, he led a team of finance professionals and played a pivotal role in the company's financial reporting, compliance, and operational efficiency initiatives.

Earlier in his career, Scott gained valuable experience as a Senior Manager in the Audit practice at KPMG, where he advised clients on accounting, auditing, and business advisory matters. His strong technical skills and consulting expertise have been instrumental in guiding organizations through complex financial and operational challenges.

Academic Background

Scott holds a Bachelor of Science degree in Accounting from the University of California, Berkeley. He is a Certified Public Accountant (CPA) and maintains a strong commitment to professional development, staying up-to-date with industry trends and best practices.

Areas of Expertise

• Corporate accounting and financial reporting

• Financial planning, analysis, and business partnering

• Treasury and cash management

• Tax compliance and optimization

• Internal controls and risk management

• Financial systems implementation and integration

• Audit and compliance management

Professional Impact

Throughout his career, Scott has demonstrated a track record of driving operational efficiency, enhancing financial visibility, and supporting strategic decision-making for his employers. He has played a pivotal role in implementing robust financial systems and reporting frameworks, which have enabled his teams to provide timely and accurate financial information to key stakeholders.

Conclusion

With his extensive finance expertise and proven leadership abilities, Scott is well-positioned to contribute to Pliant Therapeutics' continued growth and success. He is committed to leveraging his deep industry knowledge and collaborative mindset to help the organization navigate the evolving pharmaceutical landscape and achieve its long-term financial and strategic objectives.